Identification of protein markers specific for papillary renal cell carcinoma using imaging mass spectrometry

Molecules and Cells

Volumn 38, Issue 7, 2015, Pages 624-629

  Na, Chan Hyun ^a   Hong, Ji Hye ^a   Kim, Wan Sup ^b   Shanta, Selina Rahman ^a   Bang, Joo Yong ^a   Park, Dongmin ^c   Kim, Hark Kyun ^c   Kim, Kwang Pyo ^a  

^a Kyung Hee University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

Biomarker; LC MS MS; MALDI IMS; MALDI TOF; Papillary renal cell carcinoma; Proteomic analysis

Indexed keywords

FERRITIN LIGHT CHAIN PROTEIN; PROTEIN; PROTEIN S100A11; UNCLASSIFIED DRUG; FERRITIN; PROTEIN S 100; S100A11 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIDDLE AGED; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE MICROARRAY; TISSUE SECTION; CANCER STAGING; CHEMISTRY; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; TUMOR CELL LINE;

ADULT; BIOMARKERS, TUMOR; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; FERRITINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; S100 PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84949946605     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2015.0013     Document Type: Article

References (30)

1. Andersson, M., Groseclose, M.R., Deutch, A.Y., and Caprioli, R.M. (2008). Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction. Nat. Methods 5, 101-108.
2. Bosso, N., Chinello, C., Picozzi, S.C., Gianazza, E., Mainini, V., Galbusera, C., Raimondo, F., Perego, R., Casellato, S., Rocco, F, et al. (2008). Human urine biomarkers of renal cell carcinoma evaluated by ClinProt. Proteomics Clin. Appl. 2, 1036-1046.
3. Chaurand, P., Schwartz, S.A., and Caprioli, R.M. (2002). Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr. Opin. Chem. Biol. 6, 676-681.
4. Chaurand, P., Schwartz, S.A., Reyzer, M.L., and Caprioli, R.M. (2005). Imaging mass spectrometry: principles and potentials. Toxicol. Pathol. 33, 92-101.
5. Chaurand, P., Norris, J.L., Cornett, D.S., Mobley, J.A., and Caprioli, R.M. (2006). New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry. J. Proteome Res. 5, 2889-2900.
6. Essen, A., Ozen, H., Ayhan, A., Ergen, A., Tasar, C., and Remzi, F. (1991). Serum ferritin: a tumor marker for renal cell carcinoma. J. Urol. 145, 1134-1137.
7. Francese, S., Dani, F.R., Traldi, P., Mastrobuoni, G., Pieraccini, G., and Moneti, G. (2009). MALDI mass spectrometry imaging, from its origins up to today: the state of the art. Comb. Chem. High Throughput Screen 12, 156-174.
8. Fuhrman, S.A., Lasky, L.C., and Limas, C. (1982). Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 6, 655-663.
9. Kanamori, T., Takakura, K., Mandai, M., Kariya, M., Fukuhara, K., Sakaguchi, M., Huh, N.H., Saito, K., Sakurai, T., Fujita, J., et al. (2004). Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours. Mol. Hum. Reprod.10, 735-742.
10. Keller, A., Nesvizhskii, A.I., Kolker, E., and Aebersold, R. (2002). Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 5383-5392.
11. Kirkali, Z., Guzelsoy, M., Mungan, M.U., Kirkali, G., and Yorukoglu, K. (1999). Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor size and volume. Urol. Int. 62, 21-25.
12. Ljungberg, B. (2004). Prognostic factors in renal cell carcinoma. Scand. J. Surg. 93, 118-125.
13. Miyata, Y., Koga, S., Nishikido, M., Hayashi, T., and Kanetake, H. (2001). Relationship between serum ferritin levels and tumour status in patients with renal cell carcinoma. BJU Int. 88, 974-977.
14. Morgan, T.M., Seeley, E.H., Fadare, O., Caprioli, R.M., and Clark, P.E. (2013). Imaging the clear cell renal cell carcinoma proteome. J. Urol. 189, 1097-1103.
15. Motzer, R.J., Bander, N.H., and Nanus, D.M. (1996). Renal-cell carcinoma. N Engl. J. Med. 335, 865-875.
16. Ohuchida, K., Mizumoto, K., Ohhashi, S., Yamaguchi, H., Konomi, H., Nagai, E., Yamaguchi, K., Tsuneyoshi, M., and Tanaka, M. (2006). S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis. Clin. Cancer Res. 12, 5417-5422.
17. Ozen, H., Uygur, C., Sahin, A., Tekgul, S., Ergen, A., and Remzi, D. (1995). Clinical significance of serum ferritin in patients with renal cell carcinoma. Urology 46, 494-498.
18. Rehman, I., Azzouzi, A.R., Cross, S.S., Deloulme, J.C., Catto, J.W., Wylde, N., Larre, S., Champigneuille, J., and Hamdy, F.C. (2004). Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions. Hum. Pathol. 35, 1385-1391.
19. Rocca, P.C., Brunelli, M., Gobbo, S., Eccher, A., Bragantini, E., Mina, M.M., Ficarra, V., Zattoni, F., Zamo, A., Pea, M., et al. (2006). Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study. Mod. Pathol. 20, 722-728.
20. Seliger, B., Dressler, S.P., Lichtenfels, R., and Kellner, R. (2007). Candidate biomarkers in renal cell carcinoma. Proteomics 7, 4601-4612.
21. Singh, K.J., Singh, S.K., Suri, A., Vijjan, V., Goswami, A.K., and Khullar, M. (2005). Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage. Indian J. Cancer 42, 197-200.
22. Siu, K.W., DeSouza, L.V., Scorilas, A., Romaschin, A.D., Honey, R.J., Stewart, R., Pace, K., Youssef, Y., Chow, T.F., and Yousef, F. M. (2009). Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry. J. Proteome Res. 8, 3797-3807.
23. Steurer, S., Seddiqi, A.S., Singer, J.M., Bahar, A.S., Eichelberg, C., Rink, M., Dahlem, R., Huland, H., Sauter, G., Simon, R., et al. (2013). MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype. Anticancer Res. 34, 2255-2261.
24. Stoeckli, M., Chaurand, P., Hallahan, D.E., and Caprioli, R.M. (2001). Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat. Med. 7, 493-496.
25. Stulik, J., Koupilova, K., Osterreicher, J., Knizek, J., Macela, A., Bures, J., Jandik, P., Langr, F., Dedic, K., and Jungblut, P.R. (1999). Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. Electrophoresis 20, 3638-3646.
26. Torres-Cabala, C., Panizo-Santos, A., Krutzsch, H.C., Barazi, H., Namba, M., Sakaguchi, M., Roberts, D.D., and Merino, M.J. (2004). Differential expression of S100C in thyroid lesions. Int. J. Surg. Pathol. 12, 107-115.
27. Tyszkiewicz, T., Jarzab, M., Szymczyk, C., Kowal, M., Krajewska, J., Jaworska, M., Fraczek, M., Krajewska, A., Hadas, E., Swierniak, M., et al. (2014). Epidermal differentiation complex (locus 1q21) gene expression in head and neck cancer and normal mucosa. Folia Histochem. Cytobiol. 52, 79-89.
28. Unwin, R.D., Craven, R.A., Harnden, P., Hanrahan, S., Totty, N., Knowles, M., Eardley, I., Selby, P.J., and Banks, R.E. (2003). Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 3, 1620-1632.
29. Wang, G., Wang, X., Wang, S., Song, H., Sun, H., Yuan, W., Cao, B., Bai, J., and Fu, S. (2008). Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues. Int. J. Colorectal. Dis. 23, 675-682.
30. Yang, H., Zhao, K., Yu, Q., Wang, X., Song, Y., and Li, R. (2012). Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma. J. Int. Med. Res. 40, 475-485.